IRIS
BALDANTI, FAUSTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.590
AS - Asia 8.070
EU - Europa 6.734
SA - Sud America 1.393
AF - Africa 179
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 6
Totale 26.994
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.295
CN - Cina 3.572
SG - Singapore 2.046
IE - Irlanda 1.548
HK - Hong Kong 1.243
BR - Brasile 1.134
RU - Federazione Russa 1.134
DE - Germania 841
IT - Italia 797
FI - Finlandia 645
GB - Regno Unito 446
VN - Vietnam 432
UA - Ucraina 414
SE - Svezia 290
IN - India 198
FR - Francia 159
CA - Canada 155
JP - Giappone 109
AR - Argentina 102
MX - Messico 98
PL - Polonia 87
ES - Italia 70
NL - Olanda 67
TR - Turchia 65
BD - Bangladesh 64
ZA - Sudafrica 60
AT - Austria 51
IQ - Iraq 51
BE - Belgio 43
EC - Ecuador 43
ID - Indonesia 41
MA - Marocco 35
VE - Venezuela 31
PK - Pakistan 25
LT - Lituania 23
CO - Colombia 22
CZ - Repubblica Ceca 22
IR - Iran 22
AE - Emirati Arabi Uniti 19
AU - Australia 19
RO - Romania 18
AZ - Azerbaigian 17
SA - Arabia Saudita 17
IL - Israele 16
PY - Paraguay 16
KR - Corea 15
PE - Perù 14
CL - Cile 13
CH - Svizzera 12
DZ - Algeria 12
EG - Egitto 12
JO - Giordania 11
KE - Kenya 11
MU - Mauritius 11
UY - Uruguay 10
UZ - Uzbekistan 10
GR - Grecia 9
JM - Giamaica 9
KZ - Kazakistan 9
KG - Kirghizistan 8
LV - Lettonia 8
AL - Albania 7
NP - Nepal 7
PH - Filippine 7
BY - Bielorussia 6
DO - Repubblica Dominicana 6
PA - Panama 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
ET - Etiopia 5
GE - Georgia 5
HR - Croazia 5
LK - Sri Lanka 5
OM - Oman 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
AM - Armenia 4
AO - Angola 4
BH - Bahrain 4
BO - Bolivia 4
CR - Costa Rica 4
EE - Estonia 4
EU - Europa 4
LA - Repubblica Popolare Democratica del Laos 4
MD - Moldavia 4
QA - Qatar 4
SN - Senegal 4
TW - Taiwan 4
CY - Cipro 3
HU - Ungheria 3
LB - Libano 3
MY - Malesia 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BF - Burkina Faso 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
Totale 26.942
Salva come PNG Salva come JPEG
Città #
Dublin 1.527
Chandler 1.314
Hong Kong 1.240
Dallas 1.199
Ashburn 1.065
Singapore 1.002
Beijing 749
Jacksonville 575
Nanjing 505
Boardman 495
New York 379
Los Angeles 349
Munich 346
Helsinki 321
Princeton 288
Wilmington 281
Lawrence 257
Shanghai 249
Nanchang 232
Moscow 215
Redondo Beach 192
Medford 188
Hebei 183
Shenyang 173
Changsha 165
Milan 162
Jiaxing 142
Ho Chi Minh City 141
Pavia 135
Turku 133
Ann Arbor 123
Buffalo 112
São Paulo 109
Hangzhou 108
Hanoi 105
Tianjin 101
Seattle 99
Tokyo 98
Houston 86
The Dalles 84
Woodbridge 82
Brooklyn 78
Warsaw 76
Toronto 67
Chennai 61
Orem 60
Fairfield 56
Nuremberg 56
Poplar 55
Denver 51
Columbus 50
Santa Clara 50
Frankfurt am Main 49
London 49
Falkenstein 48
Pune 47
San Francisco 47
Washington 45
Boston 43
Phoenix 42
Chicago 41
Norwalk 41
Rome 41
Atlanta 40
Johannesburg 40
Mexico City 40
Brussels 39
Montreal 38
Düsseldorf 36
Stockholm 35
Rio de Janeiro 34
Ankara 33
Guangzhou 30
San Jose 30
Zhengzhou 30
Belo Horizonte 28
Jinan 27
Falls Church 26
Haiphong 21
Mumbai 21
Porto Alegre 21
Amsterdam 20
Manchester 20
Paris 20
Quito 20
Baghdad 19
Da Nang 19
Verona 19
Vienna 19
Council Bluffs 18
Guarulhos 18
Piscataway 18
Querétaro 18
Baku 17
Xi'an 16
Brasília 15
Charlotte 15
Ningbo 15
Shijiazhuang 15
Taizhou 15
Totale 17.367
Salva come PNG Salva come JPEG
Nome #
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 141
Adoptive transfer of herpesvirus-specific cytotoxic T lymphocytes in transplant recipients 138
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 128
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 125
Detection of haemagglutinin D222 polymorphisms in influenza A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing. 124
Compartmentalized replication of sars-cov-2 in upper vs. Lower respiratory tract assessed by whole genome quasispecies analysis 121
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 120
Acute cytomegalovirus infection as a cause of venous thromboembolism. 118
Accumulation of defective HIV-1 variants in a patient with slow disease progression. 116
Zika virus isolation from semen 115
A new Real-Time RT-PCR Assay for Detection of Human Enterovirus 68 (EV-D68) in Respiratory Samples. 114
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs 114
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 114
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 114
T-lymphocytes with high proliferative capacity correlate with control of viral suppression in chronically untreated HIV-1 infected individual 112
Herpes virus-6 chromosomal integration misled the management of Crohn’s disease 112
Systematic analysis of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates. 110
A novel human enterovirus C (EV-C118) identified in two children hospitalised because of acute otitis media and community-acquired pneumonia in Israel. 109
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 108
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 108
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 106
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 106
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 106
Contribution of Enteroviruses to Acute Central Nervous System or Systemic Infections in Northern Italy (2015-2017): Is It Time to Establish a National Laboratory-Based Surveillance System? 105
Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: Need for mucosal viral load measurement. 104
Diagnosis and counseling of fetal and neonatal HCMV infection. 103
Postinfectious neurologic syndromes: A prospective cohort study 103
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 103
Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic 103
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 103
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 103
Torque teno virus and cancers: current knowledge 102
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 102
Usutu Virus Antibodies in Blood Donors and Healthy Forestry Workers in the Lombardy Region, Northern Italy 102
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 102
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation 101
The pentameric complex of human cytomegalovirus: Cell tropism, virus dissemination, immune response and vaccine development 101
Viral outbreaks in neonatal intensive care units: what we do not know. 100
12 weeks ombitasvir/paritaprevir–ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 100
Concomitant Resistance to Cefiderocol and Ceftazidime/Avibactam in Two Carbapenemase-Producing Klebsiella pneumoniae Isolates from Two Lung Transplant Patients 98
Human enterovirus and parechovirus infections in newborns with sepsis-like illness and neurological disorders. 95
Persistent human cosavirus infection in lung transplant recipient, Italy. 95
Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy. 95
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 95
Expanding usutu virus circulation in italy: Detection in the Lazio region, central Italy, 2017 to 2018 95
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 94
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. 94
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 94
Authors’ reply: Two severe human cases due to swine influenza a (H1N1)v in October 2016 in Europe were chronologic coincident yet distinct events 94
Comparison of immunologic and molecular assays for the diagnosis of gastrointestinal viral infections. 94
Enterovirus-D68 (EV-D68) in pediatric patients with respiratory infection: The circulation of a new B3 clade in Italy 94
A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology 93
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey 93
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 93
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation 92
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 92
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. 92
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice 92
Monitoring of human cytomegalovirus DNAemia during primary infection in transmitter and non-transmitter mothers 91
Baseline amino acid substitutions in the NS5A ISDR and PKR binding domain of hepatitis C and different fibrosis levels and levels of development of hepatocellular carcinoma in patients treated with DAAs 91
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 91
Genome characterisation of enteroviruses 117 and 118: a new group within human enterovirus species C. 91
Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease. 91
Guillain-Barré syndrome associated with SARS-CoV-2 91
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers 91
Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy 91
Colitis in an elderly immunocompetent patient. 90
Emerging and re-emerging virus infections in neonates and young pediatric patients. 90
Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients. 89
Comparison of three different methods for the evaluation of IL28 and ITPA polymorphisms in patients infected with HCV. 89
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 89
Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. 89
Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: Implications for control strategies 89
Impact of immunosuppressive treatment on the immunogenicity of mRNA Covid-19 vaccine in vulnerable patients with giant cell arteritis 89
Imported hantavirus cardiopulmonary syndrome in an Italian traveller returning from Cuba. 88
Acute respiratory distress syndrome in adenovirus type 4 pneumonia: A case report 88
Neutrophil CD64 expression: a reliable diagnostic marker of infection in advanced cancer patients? 88
Reconstructing the recent West Nile virus lineage 2 epidemic in Europe and Italy using discrete and continuous phylogeography 88
Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study 88
Characterization of varicella-zoster (Vzv) specific t cell response in healthy subjects and transplanted patients by using enzyme linked immunospot (elispot) assays 88
A case of leprosy in a nonendemic country 88
19n01, a Broadly Neutralizing Antibody Against Omicron BA.1, BA.2, BA.4/5, and Other SARS-CoV-2 Variants of Concern 87
Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linted immunospot assay. 87
Maternal, fetal, and neonatal parameters for prognosis and counseling of HCMV congenital infection. 87
Chikungunya infection in a human immunodeficiency virus-infected kidney transplant recipient returning to Italy from the Dominican Republic 87
Frequency of respiratory viruses among patients admitted to 26 Intensive Care Units in seven consecutive winter-spring seasons (2009–2016) in Northern Italy 87
FilmArray GI panel performance for the diagnosis of acute gastroenteritis or hemorragic diarrhea 87
HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy 87
Antibody-based assay discriminates Zika virus infection from other flaviviruses 87
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 86
Circulation of two Enterovirus C105 (EV-C105) lineages in Europe and Africa. 86
Virtual quantification of influenza A virus load by real-time RT-PCR. 86
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. 86
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 86
Complete genome characterization of enterovirus 104 circulating in Northern Italy shows recombinant origin of the P3 region. 86
Frequency of respiratory virus infections and next-generation analysis of influenza A/ H1N1pdm09 dynamics in the lower respiratory tract of patients admitted to the ICU 85
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients. 84
Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial 84
Cellular DNA quantification in respiratory samples for the normalization of viral load: a real need? 84
Human Cytomegalovirus-Specific Memory CD4+T-Cell Response and Its Correlation with Virus Transmission to the Fetus in Pregnant Women with Primary Infection 84
Totale 9.791
Salva come PNG Salva come JPEG
Categoria #
all - tutte 139.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021649 0 0 0 0 0 0 52 228 77 145 107 40
2021/20221.251 23 14 27 46 52 29 33 65 72 42 179 669
2022/20234.066 405 278 77 280 328 348 6 203 1.820 41 205 75
2023/20242.446 278 396 101 128 252 594 184 159 29 100 106 119
2024/20256.630 163 452 141 215 112 391 372 382 1.658 365 727 1.652
2025/20268.441 1.189 1.051 1.881 1.796 1.870 638 16 0 0 0 0 0
Totale 27.617